Lupin gets Establishment Inspection Report for Goa facility

By: |
New Delhi | July 07, 2016 6:32 PM

Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.

Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.(Reuters)Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.(Reuters)

Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.

The company “has received notification that the inspection carried out by the United States Food and Drug Administration (USFDA) in July 2015 at its Goa facility is now closed and the agency has now issued an EIR,” Lupin said in a filing to BSE.

However the responses from March’s USFDA inspection and updates thereafter are still under the review of the agency, it added.

The company’s Goa facility supplies over 100 products to various regulated markets including the US and EU. The plant has filed more than 115 abbreviated new drug applications (ANDA’s) in the US market.

Lupin has also filed for ANDAs for markets like the EU, Japan and Brazil from the facility.

Shares of Lupin today closed at Rs 1,657.30 on BSE, up 6.25 per cent from the previous close.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Lanco Infratech declared as ‘fraud’ account by Punjab & Sind Bank
2We’re betting on pick-up in capital expenditure; bullish on SME sector: Rajiv Anand, executive director wholesale banking, Axis Bank
3Small Finance Banks receive fresh credit requests from MFIs after RBI’s PSL classification